Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.97
CHDX's Cash to Debt is ranked higher than
73% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.62 vs. CHDX: 0.97 )
CHDX' s 10-Year Cash to Debt Range
Min: 0.5   Max: No Debt
Current: 0.97

Equity to Asset 0.65
CHDX's Equity to Asset is ranked higher than
87% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. CHDX: 0.65 )
CHDX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.76
Current: 0.65

0.3
0.76
Interest Coverage 1.19
CHDX's Interest Coverage is ranked lower than
58% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. CHDX: 1.19 )
CHDX' s 10-Year Interest Coverage Range
Min: 0.93   Max: 9999.99
Current: 1.19

0.93
9999.99
F-Score: 4
Z-Score: 3.88
M-Score: -2.90
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -0.72
CHDX's Operating margin (%) is ranked lower than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.73 vs. CHDX: -0.72 )
CHDX' s 10-Year Operating margin (%) Range
Min: -714.57   Max: 8.42
Current: -0.72

-714.57
8.42
Net-margin (%) -5.15
CHDX's Net-margin (%) is ranked lower than
53% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. CHDX: -5.15 )
CHDX' s 10-Year Net-margin (%) Range
Min: -19.33   Max: 4.79
Current: -5.15

-19.33
4.79
ROE (%) -6.37
CHDX's ROE (%) is ranked lower than
55% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.14 vs. CHDX: -6.37 )
CHDX' s 10-Year ROE (%) Range
Min: -27.79   Max: 10.82
Current: -6.37

-27.79
10.82
ROA (%) -4.21
CHDX's ROA (%) is ranked lower than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.17 vs. CHDX: -4.21 )
CHDX' s 10-Year ROA (%) Range
Min: -16.55   Max: 4.92
Current: -4.21

-16.55
4.92
ROC (Joel Greenblatt) (%) -1.28
CHDX's ROC (Joel Greenblatt) (%) is ranked lower than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 25.75 vs. CHDX: -1.28 )
CHDX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5035.79   Max: 33.08
Current: -1.28

-5035.79
33.08
Revenue Growth (3Y)(%) 0.20
CHDX's Revenue Growth (3Y)(%) is ranked higher than
53% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. CHDX: 0.20 )
CHDX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -24   Max: 100.4
Current: 0.2

-24
100.4
EBITDA Growth (3Y)(%) -13.40
CHDX's EBITDA Growth (3Y)(%) is ranked lower than
55% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. CHDX: -13.40 )
CHDX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -22.4   Max: 71.8
Current: -13.4

-22.4
71.8
» CHDX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

CHDX Guru Trades in Q2 2013

Jim Simons Sold Out
» More
Q1 2014

CHDX Guru Trades in Q1 2014

Jim Simons 57,234 sh (New)
» More
Q2 2014

CHDX Guru Trades in Q2 2014

Jim Simons 124,900 sh (+118.23%)
» More
Q3 2014

CHDX Guru Trades in Q3 2014

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with CHDX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.68
CHDX's P/B is ranked higher than
70% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.03 vs. CHDX: 2.68 )
CHDX' s 10-Year P/B Range
Min: 0.55   Max: 8.09
Current: 2.68

0.55
8.09
P/S 2.12
CHDX's P/S is ranked higher than
61% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.95 vs. CHDX: 2.12 )
CHDX' s 10-Year P/S Range
Min: 0.27   Max: 2.87
Current: 2.12

0.27
2.87
EV-to-EBIT -307.67
CHDX's EV-to-EBIT is ranked lower than
63% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.48 vs. CHDX: -307.67 )
CHDX' s 10-Year EV-to-EBIT Range
Min: -308.6   Max: 506.7
Current: -307.67

-308.6
506.7
Shiller P/E 123.55
CHDX's Shiller P/E is ranked higher than
68% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 42.91 vs. CHDX: 123.55 )
CHDX' s 10-Year Shiller P/E Range
Min: 24.41   Max: 757.5
Current: 123.55

24.41
757.5
Current Ratio 1.57
CHDX's Current Ratio is ranked higher than
66% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. CHDX: 1.57 )
CHDX' s 10-Year Current Ratio Range
Min: 1.12   Max: 5.37
Current: 1.57

1.12
5.37
Quick Ratio 1.51
CHDX's Quick Ratio is ranked higher than
81% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. CHDX: 1.51 )
CHDX' s 10-Year Quick Ratio Range
Min: 0.73   Max: 5.29
Current: 1.51

0.73
5.29

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.68
CHDX's Price/Tangible Book is ranked higher than
76% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.89 vs. CHDX: 2.68 )
CHDX' s 10-Year Price/Tangible Book Range
Min: 0.19   Max: 5.63
Current: 2.68

0.19
5.63
Price/DCF (Projected) 6.34
CHDX's Price/DCF (Projected) is ranked higher than
68% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. CHDX: 6.34 )
CHDX' s 10-Year Price/DCF (Projected) Range
Min: 1.24   Max: 59.03
Current: 6.34

1.24
59.03
Price/Median PS Value 1.69
CHDX's Price/Median PS Value is ranked higher than
56% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.33 vs. CHDX: 1.69 )
CHDX' s 10-Year Price/Median PS Value Range
Min: 0.08   Max: 2.01
Current: 1.69

0.08
2.01
Earnings Yield (Greenblatt) -0.30
CHDX's Earnings Yield (Greenblatt) is ranked higher than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. CHDX: -0.30 )
CHDX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 73.4
Current: -0.3

0.2
73.4
Forward Rate of Return (Yacktman) -8.69
CHDX's Forward Rate of Return (Yacktman) is ranked lower than
55% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.44 vs. CHDX: -8.69 )
CHDX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -32.7   Max: 31.1
Current: -8.69

-32.7
31.1

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Chindex International, Inc., was founded in 1981 in Delaware. The Company operates in several healthcare markets in China, including Hong Kong. It generates its revenue from the provision of healthcare services and the sale of medical equipment, instrumentation and products. The Company operates in two business segments: the Medical Product Division and the Healthcare Services Division. It operates hospitals and clinics in Beijing, Shanghai, Tianjin and Guangzhou. These hospitals and clinics generally transact business in Chinese Renminbi. The Company historically also engaged in the distribution of western medical equipment to Chinese hospital purchasers through its former Medical Products division ("MPD"). Its Healthcare Services Business includes: United Family Beijing Market - Beijing United Family Hospital (BJU) and Clinics, United Family Shanghai Market—Shanghai United Family Hospital (SHU) and Clinics, United Family Tianjin Market - Tianjin United Family Hospital (TJU), United Family Guangzhou Market - Guangzhou United Family Clinic (GZC), United Family - The Investment Environment and New Market Development. There are no foreign investor-owned and operated hospital networks in China that compete with the United Family healthcare network in serving the expatriate, diplomatic and affluent local Chinese markets through a healthcare service delivery system.
» More Articles for CHDX

Headlines

Articles On GuruFocus.com
Chindex International Inc. Reports Operating Results (10-Q) Nov 08 2010 
Chindex International Inc. (CHDX) CEO and President Roberta Lipson sells 17,000 Shares Sep 15 2010 
Chindex International Inc. Reports Operating Results (10-Q) Aug 09 2010 
Chindex International Inc. Reports Operating Results (10-Q) Feb 08 2010 
Chindex International Inc. Reports Operating Results (10-Q) Nov 09 2009 
Chindex International Inc. Reports Operating Results (10-Q) Aug 10 2009 
Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results Aug 10 2009 
Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results Feb 09 2009 

More From Other Websites
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion... Sep 30 2014
Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. Sep 30 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Sep 19 2014
Chindex Stockholders Approve Merger Sep 16 2014
ISS and Glass Lewis Recommend that Chindex International, Inc. Shareholders Vote "FOR" the Proposed... Sep 04 2014
CHINDEX INTERNATIONAL INC Financials Aug 19 2014
Chindex International, Inc. Provides Update to Stockholders Regarding Special Meeting of... Aug 14 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 11 2014
CHINDEX INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Aug 11 2014
Chindex International, Inc. Reports Financial Results for Second Quarter and First Half of 2014 Aug 11 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Aug 07 2014
Giant, RDA De-List As Deal-Making Slows Jul 22 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 30 2014
China healthcare reform to relax curbs on foreign investment in hospitals May 28 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 12 2014
Chindex International, Inc. Reports First Quarter 2014 Financial Results May 08 2014
Chindex Signs Previously-Disclosed Joint Venture Regarding Guangzhou United Family Hospital May 06 2014
Chindex International, Inc. to Report First Quarter 2014 Financial Results Apr 30 2014
China Biotech Week In Review: Chindex Taken Private By Fosun And TPG Apr 27 2014
The Alexander Firm P.C. Announces Investigation of Chindex International, Inc. and Its Board of... Apr 24 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK